Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R CURTISS

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
American Journal of Hospital Pharmacy|January 1, 1986
Recent developments in federal reimbursement for home health careF R Curtiss
American Journal of Hospital Pharmacy|April 1, 1989
Managed health careF R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 20, 2006
Pharmacy benefit spending on oral chemotherapy drugsFrederic R Curtiss
American Journal of Hospital Pharmacy|April 1, 1984
Final regulations on Medicare prospective pricingF R Curtiss
American Journal of Hospital Pharmacy|August 1, 1988
Recent developments in federal reimbursement for home health-care services and productsF R Curtiss
American Journal of Hospital Pharmacy|October 1, 1986
Methods of providing prescription drug benefits in health plansF R Curtiss
American Journal of Hospital Pharmacy|October 1, 1985
Analysis of nationwide pharmacy charges per DRGF R Curtiss
Biochemistry International|October 1, 1991
Hormonotoxins: abrogation of ribosome inactivating property of gelonin in the disulfide linked ovine luteinizing hormone-gelonin conjugatesV Singh, R Curtiss
Molecular and Cellular Biochemistry|January 12, 1994
Hormonotoxins: the role of positive charge of lysine residue on the immunological, biological and cytotoxic properties of ovine lutropin-S-S-gelonin conjugatesV Singh, R Curtiss
Molecular and Cellular Biochemistry|January 12, 1994
Effect of amino group modification of ovine luteinizing hormone (oLH) by N-succinimidyl 6-[3-(2-pyridyldithio)propionate]hexanoate, a long chain N-succinimidyl-3-(2-pyridyldithio) propionate (SPDP) on immunological and biological properties: a comparative study with SPDP modified oLHV Singh, R Curtiss
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
American Journal of Hospital Pharmacy|January 1, 1986
Recent developments in federal reimbursement for home health careF R Curtiss
American Journal of Hospital Pharmacy|April 1, 1989
Managed health careF R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 20, 2006
Pharmacy benefit spending on oral chemotherapy drugsFrederic R Curtiss
American Journal of Hospital Pharmacy|April 1, 1984
Final regulations on Medicare prospective pricingF R Curtiss
American Journal of Hospital Pharmacy|August 1, 1988
Recent developments in federal reimbursement for home health-care services and productsF R Curtiss
American Journal of Hospital Pharmacy|October 1, 1986
Methods of providing prescription drug benefits in health plansF R Curtiss
American Journal of Hospital Pharmacy|October 1, 1985
Analysis of nationwide pharmacy charges per DRGF R Curtiss
Biochemistry International|October 1, 1991
Hormonotoxins: abrogation of ribosome inactivating property of gelonin in the disulfide linked ovine luteinizing hormone-gelonin conjugatesV Singh, R Curtiss
Molecular and Cellular Biochemistry|January 12, 1994
Hormonotoxins: the role of positive charge of lysine residue on the immunological, biological and cytotoxic properties of ovine lutropin-S-S-gelonin conjugatesV Singh, R Curtiss
Molecular and Cellular Biochemistry|January 12, 1994
Effect of amino group modification of ovine luteinizing hormone (oLH) by N-succinimidyl 6-[3-(2-pyridyldithio)propionate]hexanoate, a long chain N-succinimidyl-3-(2-pyridyldithio) propionate (SPDP) on immunological and biological properties: a comparative study with SPDP modified oLHV Singh, R Curtiss
Pageof 17